Latest News - Acquisitions/Mergers

Monday, February 27, 2017 | Acquisitions/Mergers, Abbott Medical Optics, AMO, Johnson & Johnson Vision Care

Johnson & Johnson Completes Acquisition of Abbott Medical Optics

Johnson & Johnson announced that it has completed the acquisition of Abbott Medical Optics (AMO) in an all-cash deal worth $4.325 billion. The deal, which was originally announced September 16, 20…

Read the full story

Tuesday, February 21, 2017 | Acquisitions/Mergers, Eyegate Pharmaceuticals, Valeant

Valeant and Eyegate Enter into Licensing Agreement for EyeGate II Delivery System and EGP-437 Combination Product

Valeant Pharmaceuticals International and EyeGate Pharmaceuticals announced that they have entered into an exclusive, worldwide licensing agreement through which EyeGate has granted a subsidiary of Va…

Read the full story

Thursday, February 16, 2017 | Acquisitions/Mergers, Retina

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Next-Generation Retinal Disease Therapy From University of Pittsburgh

BioTime announced that the company has obtained a worldwide license to intellectual property (IP) assets from University of Pittsburgh. The technology was developed in part in collaboration with BioTi…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Thursday, February 09, 2017 | Acquisitions/Mergers

Lions Eye Institute for Transplant & Research Doubles Its Size After Acquisition of International Sight Restoration

The Lions Eye Institute for Transplant & Research (LEITR) announced the acquisition of International Sight Restoration (ISR) in Tampa to double its size, creating one of the largest eye banks and …

Read the full story

Monday, February 06, 2017 | Acquisitions/Mergers, AMD

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Retinal Disease Therapy From University of Pittsburgh Medical Center

BioTime announced the acquisition of global rights to ophthalmology-related intellectual property assets from the University of Pittsburgh’s Medical Center (UPMC), via the school’s Innovat…

Read the full story

Thursday, January 26, 2017 | Acquisitions/Mergers, Johnson & Johnson Vision Care

Johnson & Johnson To Acquire Actelion For $30 Billion With Spin-Out Of New R&D Company

Johnson & Johnson, which in September agreed to acquire Abbott Medical Optics for $4.325 billion in cash, announced that it has agreed to acquired Actelion for $280 per share in cash, or $30 …

Read the full story

Tuesday, January 24, 2017 | Acquisitions/Mergers

Hilco Vision Announces the Acquisition of Croakies Inc.

Hilco Vision announced the acquisition of Croakies, the Wyoming-based originator of eyewear retainers and associated outdoor lifestyle accessories. Terms of the deal were not disclosed. "Hi…

Read the full story

Monday, January 16, 2017 | Acquisitions/Mergers

Essilor to Merge with Ray-Ban Maker Luxottica to Create $49 Billion Eyewear Giant

In a massive merger agreement that would reshape the eyewear industry, Luxottica Group, maker of Ray-Ban sunglasses, has agreed to a merger with French optical-lens maker Essilor International. Und…

Read the full story

Friday, January 13, 2017 | Acquisitions/Mergers, AMD, ForSight Vision

ForSight Vision 4 Announces Acquisition by Roche

ForSight Vision 4 announced that it has been acquired by Roche Holdings. The acquisition expands Roche's exclusive access to the ForSight Vision 4 PDS technology for long-acting delivery of therap…

Read the full story

Wednesday, December 21, 2016 | Acquisitions/Mergers, Allergan

Allergan to Acquire Acelity LifeCell Corporation for $2.9 Billion

Allergan and Acelity announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for $2.9 billion in cash. The…

Read the full story

Tuesday, December 20, 2016 | Acquisitions/Mergers, Novartis

Novartis Bolsters Ophthalmology Pipeline Through Acquisition of Encore Vision

Novartis announced that it has entered into a definitive agreement to acquire Encore Vision, a company focused on the development of a novel treatment in presbyopia. Terms of the deal were not disc…

Read the full story

Wednesday, December 14, 2016 | Acquisitions/Mergers, Acucela, AMD

Acucela Secures Option to Exclusively Acquire Novel Retinal Technology

Acucela announced an R&D agreement and exclusive option to acquire the global rights to EyeMedics' proprietary biomimetic technology, including an initial candidate molecule for ophthalmic use…

Read the full story

Tuesday, December 06, 2016 | Acquisitions/Mergers

RightEye Developing Eye-Tracking Test for Reading Disorders

RightEye announced that it has acquired the exclusive license to create an objective, repeatable test to identify reading disorders in students at all grade levels. The new test, which assesses eye mo…

Read the full story

Monday, December 05, 2016 | Acquisitions/Mergers

Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences

Spark Therapeutics, which is undergoing investigational development programs in inherited retinal diseases (IRDs), and Selecta Biosciences announced a license agreement that provides Spark Therapeutic…

Read the full story
Load More